Treatment News : Credit Scoring Company Turns Technology to Predicting Med Adherence

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » June 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


June 22, 2011

Credit Scoring Company Turns Technology to Predicting Med Adherence

FICO, the credit scoring giant, says it is going to start using its mathematical technology to inform the health insurance industry about which people will be most at risk of not adhering to their medication.

“We started thinking about how consumers behave as patients,” said Mark Greene, the chief executive of FICO, based in Minneapolis, to New York Times blogger Tara Parker-Pope. “The problem, from a math standpoint, is not all that different from banking and other industries.”

Nearly three quarters of all people fail to take their medication exactly as prescribed by their doctors. Though studies have shown that medication adherence is generally higher among people living with HIV, the consequences of missed doses are significant, and between one quarter and one half of HIV-positive people struggle with adherence. People who miss too many doses of their antiretroviral (ARV) medication often develop HIV drug resistance and end up in treatment failure.

Fico said that by end of the 2011, an estimated 2 to 3 million people will have been given a FICO medication adherence score and that a total of 10 million people are expected to be scored by the summer of 2012.

Because the company will use publicly available data, such as home ownership and job status, rather than medical records, the score can be compiled without requiring sensitive and private health information. Right now, the company will be offering its adherence rating services to health insurance companies so that they can offer additional assistance to those who FICO predicts will have the most trouble.

FICO built its adherence score, which will range from 0 and 500, from data provided on 600,000 patients by a large pharmacy benefits management company. People who scored 400 or higher on FICO’s system were judged to be highly likely to adhere to their medication, while those with a score below 200 were expected to have adherence problems.

FICO hasn’t specified whether it will be offering its score to HIV health care providers, though it is likely that HIV-positive people will be included if they are covered by insurance plans that use FICO’s adherence scoring service.

“We view this as a public health problem,” said Rebecca Burkholder, vice president of health policy for the National Consumers League. “We really believe that encouraging that conversation between patient and professional can help them better understand their condition and the consequences of not taking their medicine.”

Search: FICO, credit score, adherence score, Mark Greene, Tara Parker-Pope, Rebecca Burkholder, National Consumers League

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (12 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.